MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xiao, Y.
Right arrow Articles by Kellar, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiao, Y.
Right arrow Articles by Kellar, K. J.

Vol. 54, Issue 2, 322-333, August 1998

Rat alpha 3/beta 4 Subtype of Neuronal Nicotinic Acetylcholine Receptor Stably Expressed in a Transfected Cell Line: Pharmacology of Ligand Binding and Function

Yingxian Xiao, Erin L. Meyer, Jessica M. Thompson, Alexander Surin, Jarda Wroblewski, and Kenneth J. Kellar

Department of Pharmacology, Georgetown University School of Medicine, Washington, DC 20007

We stably transfected human kidney embryonic 293 cells with the rat neuronal nicotinic acetylcholine receptor (nAChR) alpha 3 and beta 4 subunit genes. This new cell line, KXalpha 3beta 4R2, expresses a high level of the alpha 3/beta 4 receptor subtype, which binds (±)- [3H]epibatidine with a Kd value of 304±16 pM and a Bmax value of 8942 ± 115 fmol/mg protein. Comparison of nicotinic drugs in competing for alpha 3/beta 4 receptor binding sites in this cell line and the binding sites in rat forebrain (predominantly alpha 4/beta 2 receptors) revealed marked differences in their Ki values, but similar rank orders of potency for agonists were observed, with the exception of anatoxin-A. The affinity of the competitive antagonist dihydro-beta -erythroidine is >7000 times higher at alpha 4/beta 2 receptors in rat forebrain than at the alpha 3/beta 4 receptors in these cells. The alpha 3/beta 4 nAChRs expressed in this cell line are functional, and in response to nicotinic agonists, 86Rb+ efflux was increased to levels 8-10 times the basal levels. Acetylcholine, (-)-nicotine, cytisine, carbachol, and (±)-epibatidine all stimulated 86Rb+ efflux, which was blocked by mecamylamine. The EC50 values for acetylcholine and (-)-nicotine to stimulate 86Rb+ effluxes were 114 ± 24 and 28 ± 4 µM, respectively. The rank order of potency of nicotinic antagonists in blocking the function of this alpha 3/beta 4 receptor was mecamylamine > d-tubocurarine > dihydro-beta -erythroidine > hexamethonium. Mecamylamine, d-tubocurarine, and hexamethonium blocked the function by a noncompetitive mechanism, whereas dihydro-beta -erythroidine blocked the function competitively. The KXalpha 3beta 4R2 cell line should prove to be a very useful model for studying this subtype of nAChRs.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. A. Decker and J. J. Galligan
Cross-inhibition between nicotinic acetylcholine receptors and P2X receptors in myenteric neurons and HEK-293 cells
Am J Physiol Gastrointest Liver Physiol, June 1, 2009; 296(6): G1267 - G1276.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Armishaw, A. A. Jensen, T. Balle, R. J. Clark, K. Harpsoe, C. Skonberg, T. Liljefors, and K. Stromgaard
Rational Design of {alpha}-Conotoxin Analogues Targeting {alpha}7 Nicotinic Acetylcholine Receptors: IMPROVED ANTAGONISTIC ACTIVITY BY INCORPORATION OF PROLINE DERIVATIVES
J. Biol. Chem., April 3, 2009; 284(14): 9498 - 9512.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. F. Gonzalez-Cestari, B. J. Henderson, R. E. Pavlovicz, S. B. McKay, R. A. El-Hajj, A. B. Pulipaka, C. M. Orac, D. D. Reed, R. T. Boyd, M. X. Zhu, et al.
Effect of Novel Negative Allosteric Modulators of Neuronal Nicotinic Receptors on Cells Expressing Native and Recombinant Nicotinic Receptors: Implications for Drug Discovery
J. Pharmacol. Exp. Ther., February 1, 2009; 328(2): 504 - 515.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. C. Gahring, A. V. Osborne-Hereford, G. A. Vasquez-Opazo, and S. W. Rogers
Tumor Necrosis Factor {alpha} Enhances Nicotinic Receptor Up-regulation via a p38MAPK-dependent Pathway
J. Biol. Chem., January 11, 2008; 283(2): 693 - 699.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. B. McKay, C. Chang, T. F. Gonzalez-Cestari, S. B. McKay, R. A. El-Hajj, D. L. Bryant, M. X. Zhu, P. W. Swaan, K. M. Arason, A. B. Pulipaka, et al.
Analogs of Methyllycaconitine as Novel Noncompetitive Inhibitors of Nicotinic Receptors: Pharmacological Characterization, Computational Modeling, and Pharmacophore Development
Mol. Pharmacol., May 1, 2007; 71(5): 1288 - 1297.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
Y. Pankratov, U. Lalo, A. Verkhratsky, and R. A. North
Quantal Release of ATP in Mouse Cortex
J. Gen. Physiol., March 26, 2007; 129(3): 257 - 265.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Mao, R. P. Yasuda, H. Fan, B. B. Wolfe, and K. J. Kellar
Heterogeneity of Nicotinic Cholinergic Receptors in Rat Superior Cervical and Nodose Ganglia
Mol. Pharmacol., November 1, 2006; 70(5): 1693 - 1699.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. Le Magueresse, V. Safiulina, J.-P. Changeux, and E. Cherubini
Nicotinic modulation of network and synaptic transmission in the immature hippocampus investigated with genetically modified mice
J. Physiol., October 15, 2006; 576(2): 533 - 546.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Xiao, H. Fan, J. L. Musachio, Z.-L. Wei, S. K. Chellappan, A. P. Kozikowski, and K. J. Kellar
Sazetidine-A, A Novel Ligand That Desensitizes {alpha}4beta2 Nicotinic Acetylcholine Receptors without Activating Them
Mol. Pharmacol., October 1, 2006; 70(4): 1454 - 1460.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Ohtani, T. Oka, M. Badyuk, Y. Xiao, K. J. Kellar, and J. W. Daly
Mouse beta-TC6 Insulinoma Cells: High Expression of Functional {alpha}3beta4 Nicotinic Receptors Mediating Membrane Potential, Intracellular Calcium, and Insulin Release
Mol. Pharmacol., March 1, 2006; 69(3): 899 - 907.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Barik and S. Wonnacott
Indirect Modulation by {alpha}7 Nicotinic Acetylcholine Receptors of Noradrenaline Release in Rat Hippocampal Slices: Interaction with Glutamate and GABA Systems and Effect of Nicotine Withdrawal
Mol. Pharmacol., February 1, 2006; 69(2): 618 - 628.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. M. Marritt, B. C. Cox, R. P. Yasuda, J. M. McIntosh, Y. Xiao, B. B. Wolfe, and K. J. Kellar
Nicotinic Cholinergic Receptors in the Rat Retina: Simple and Mixed Heteromeric Subtypes
Mol. Pharmacol., December 1, 2005; 68(6): 1656 - 1668.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
P. J. Zhu, R. R. Stewart, J. M. McIntosh, and F. F. Weight
Activation of Nicotinic Acetylcholine Receptors Increases the Frequency of Spontaneous GABAergic IPSCs in Rat Basolateral Amygdala Neurons
J Neurophysiol, November 1, 2005; 94(5): 3081 - 3091.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. R. Turner and K. J. Kellar
Nicotinic Cholinergic Receptors in the Rat Cerebellum: Multiple Heteromeric Subtypes
J. Neurosci., October 5, 2005; 25(40): 9258 - 9265.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. C. Hernandez, S. Vicini, Y. Xiao, M. I. Davila-Garcia, R. P. Yasuda, B. B. Wolfe, and K. J. Kellar
The Nicotinic Receptor in the Rat Pineal Gland Is an {alpha}3{beta}4 Subtype
Mol. Pharmacol., October 1, 2004; 66(4): 978 - 987.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Mamede, K. Ishizu, M. Ueda, T. Mukai, Y. Iida, H. Fukuyama, T. Saga, and H. Saji
Quantification of Human Nicotinic Acetylcholine Receptors with 123I-5IA SPECT
J. Nucl. Med., September 1, 2004; 45(9): 1458 - 1470.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Xiao and K. J. Kellar
The Comparative Pharmacology and Up-Regulation of Rat Neuronal Nicotinic Receptor Subtype Binding Sites Stably Expressed in Transfected Mammalian Cells
J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 98 - 107.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. L. Parker, Y. Fu, K. McAllen, J. Luo, J. M. McIntosh, J. M. Lindstrom, and B. M. Sharp
Up-Regulation of Brain Nicotinic Acetylcholine Receptors in the Rat during Long-Term Self-Administration of Nicotine: Disproportionate Increase of the {alpha}6 Subunit
Mol. Pharmacol., March 1, 2004; 65(3): 611 - 622.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. P. Boorman, M. Beato, P. J. Groot-Kormelink, S. D. Broadbent, and L. G. Sivilotti
The Effects of {beta}3 Subunit Incorporation on the Pharmacology and Single Channel Properties of Oocyte-expressed Human {alpha}3{beta}4 Neuronal Nicotinic Receptors
J. Biol. Chem., November 7, 2003; 278(45): 44033 - 44040.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. A. Jensen, I. Mikkelsen, B. Frolund, H. Brauner-Osborne, E. Falch, and P. Krogsgaard-Larsen
Carbamoylcholine Homologs: Novel and Potent Agonists at Neuronal Nicotinic Acetylcholine Receptors
Mol. Pharmacol., October 1, 2003; 64(4): 865 - 875.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. M. Avila, M. I. Davila-Garcia, V. S. Ascarrunz, Y. Xiao, and K. J. Kellar
Differential Regulation of Nicotinic Acetylcholine Receptors in PC12 Cells by Nicotine and Nerve Growth Factor
Mol. Pharmacol., October 1, 2003; 64(4): 974 - 986.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. Alkondon, E. F.R. Pereira, and E. X. Albuquerque
NMDA and AMPA Receptors Contribute to the Nicotinic Cholinergic Excitation of CA1 Interneurons in the Rat Hippocampus
J Neurophysiol, September 1, 2003; 90(3): 1613 - 1625.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. K. Miller, E. H. F. Wong, M. D. Chesnut, and L. P. Dwoskin
Reboxetine: Functional Inhibition of Monoamine Transporters and Nicotinic Acetylcholine Receptors
J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 687 - 695.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Abdrakhmanova, J. Dorfman, Y. Xiao, and M. Morad
Protons Enhance the Gating Kinetics of the alpha 3/beta 4 Neuronal Nicotinic Acetylcholine Receptor by Increasing Its Apparent Affinity to Agonists
Mol. Pharmacol., February 1, 2002; 61(2): 369 - 378.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Xiao, R. D. Smith, F. S. Caruso, and K. J. Kellar
Blockade of Rat alpha 3beta 4 Nicotinic Receptor Function by Methadone, Its Metabolites, and Structural Analogs
J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 366 - 371.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. J. Parker, S. C. Harvey, and C. W. Luetje
Determinants of Agonist Binding Affinity on Neuronal Nicotinic Receptor beta Subunits
J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 385 - 391.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. L. Meyer, Y. Xiao, and K. J. Kellar
Agonist Regulation of Rat alpha 3beta 4 Nicotinic Acetylcholine Receptors Stably Expressed in Human Embryonic Kidney 293 Cells
Mol. Pharmacol., September 1, 2001; 60(3): 568 - 576.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. A. Giniatullin, E. M. Sokolova, S. Di Angelantonio, A. Skorinkin, M. V. Talantova, and A. Nistri
Rapid Relief of Block by Mecamylamine of Neuronal Nicotinic Acetylcholine Receptors of Rat Chromaffin Cells In Vitro: An Electrophysiological and Modeling Study
Mol. Pharmacol., October 1, 2000; 58(4): 778 - 787.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
S. C. Hernandez, M. Bertolino, Y. Xiao, K. E. Pringle, F. S. Caruso, and K. J. Kellar
Dextromethorphan and Its Metabolite Dextrorphan Block alpha 3beta 4 Neuronal Nicotinic Receptors
J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 962 - 967.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
A. G. Mukhin, D. Gündisch, A. G. Horti, A. O. Koren, G. Tamagnan, A. S. Kimes, J. Chambers, D. B. Vaupel, S. L. King, M. R. Picciotto, et al.
5-Iodo-A-85380, an alpha 4beta 2 Subtype-Selective Ligand for Nicotinic Acetylcholine Receptors
Mol. Pharmacol., March 1, 2000; 57(3): 642 - 649.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
S. Vailati, W. Hanke, A. Bejan, B. Barabino, R. Longhi, B. Balestra, M. Moretti, F. Clementi, and C. Gotti
Functional alpha 6-Containing Nicotinic Receptors Are Present in Chick Retina
Mol. Pharmacol., July 1, 1999; 56(1): 11 - 19.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
D. C. Perry, M. I. Dávila-García, C. A. Stockmeier, and K. J. Kellar
Increased Nicotinic Receptors in Brains from Smokers: Membrane Binding and Autoradiography Studies
J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1545 - 1552.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
J. Zhang, Y. Xiao, G. Abdrakhmanova, W. Wang, L. Cleemann, K.J. Kellar, and M. Morad
Activation and Ca2+ Permeation of Stably Transfected alpha 3/beta 4 Neuronal Nicotinic Acetylcholine Receptor
Mol. Pharmacol., June 1, 1999; 55(6): 970 - 981.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
M. J. Parker, A. Beck, and C. W. Luetje
Neuronal Nicotinic Receptor beta 2 and beta 4 Subunits Confer Large Differences in Agonist Binding Affinity
Mol. Pharmacol., December 1, 1998; 54(6): 1132 - 1139.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics